Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Share-based Compensation (2016 - 2025)

Orthofix Medical's Share-based Compensation history spans 15 years, with the latest figure at $7.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 0.68% year-over-year to $7.2 million, compared with a TTM value of $28.7 million through Dec 2025, down 11.61%, and an annual FY2025 reading of $28.7 million, down 11.61% over the prior year.
  • Share-based Compensation for Q4 2025 was $7.2 million at Orthofix Medical, roughly flat from $7.2 million in the prior quarter.
  • The five-year high for Share-based Compensation was $13.2 million in Q2 2023, with the low at $3.2 million in Q4 2023.
  • Average Share-based Compensation over 5 years is $6.5 million, with a median of $6.4 million recorded in 2023.
  • Biggest YoY gain for Share-based Compensation was 200.55% in 2023; the steepest drop was 35.66% in 2023.
  • Tracing OFIX's Share-based Compensation over 5 years: stood at $4.0 million in 2021, then rose by 24.23% to $4.9 million in 2022, then crashed by 35.66% to $3.2 million in 2023, then soared by 126.24% to $7.2 million in 2024, then grew by 0.68% to $7.2 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Share-based Compensation are $7.2 million (Q4 2025), $7.2 million (Q3 2025), and $7.8 million (Q2 2025).